These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4399498)

  • 21. Effect of post-trial injection of beta adrenergic blocking agents on a conditioned reflex in rats.
    Merlo AB; Izquierdo JA
    Psychopharmacologia; 1971; 22(2):181-6. PubMed ID: 4399389
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of -adrenoceptor antagonists on the decline of the chronotropic response to isoprenaline.
    Fenyvesi T; George CF; Dollery CT
    J Pharm Pharmacol; 1972 Apr; 24(4):313-7. PubMed ID: 4402839
    [No Abstract]   [Full Text] [Related]  

  • 23. Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
    Hellenbrecht D; Lemmer B; Wiethold G; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(2):211-26. PubMed ID: 4145013
    [No Abstract]   [Full Text] [Related]  

  • 24. The blocking effects of propranolol, practolol and ICI-66082 on the peripheral vascular responses to isoprenaline.
    Hainsworth R; Karim F; Stoker JB; Harry JD
    Br J Pharmacol; 1973 Jun; 48(2):342P-343P. PubMed ID: 4147430
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of six adrenergic beta receptor blockaders on auriculo-ventricular conduction in the dog].
    Giudicelli JF; Boissier JR
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):287-92. PubMed ID: 4402114
    [No Abstract]   [Full Text] [Related]  

  • 26. Pressor effect of beta blocking agents in rats.
    Regoli D; Regoli U; Gysling E
    Can J Physiol Pharmacol; 1972 Mar; 50(3):207-14. PubMed ID: 4402339
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of propranolol, INPEA, iproveratril and some 1-naphthylethylamine derivatives on the myocardial phosphorylase activity.
    Robak J; Gryglewski R
    Biochem Pharmacol; 1970 Apr; 19(4):1221-7. PubMed ID: 4398008
    [No Abstract]   [Full Text] [Related]  

  • 28. [Quantitative comparison of the effects of various beta-adrenergic receptor antagonists in healthy subjects at rest and during infusions of isoproterenol].
    Bender F; Sieger W; Dotterweich K
    Arztl Forsch; 1969 Nov; 23(11):359-65. PubMed ID: 4391417
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
    Kadatz R; Diederen W
    Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
    [No Abstract]   [Full Text] [Related]  

  • 30. Treadmill exercise in dogs under -adrenergic blockade: adaptation of coronary and systemic hemodynamics.
    Bassenge E; Kucharczyk M; Holtz J; Stoian D
    Pflugers Arch; 1972; 332(1):40-55. PubMed ID: 4401667
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective beta adrenergic receptor blockade in the rat.
    Wasserman MA; Levy B
    J Pharmacol Exp Ther; 1972 Aug; 182(2):256-63. PubMed ID: 4403093
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacology of M & B 17803A in man and dog.
    Briant RH; Dollery CT; Fenyvesi T; George CF
    Br J Pharmacol; 1971 Oct; 43(2):468P-469P. PubMed ID: 4400577
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanism of broncho-constrictor action of some adrenergic beta-receptor antagonists.
    Saini RK; Sharma PL; Chaudhury RR
    Indian J Med Res; 1972 Feb; 60(2):260-5. PubMed ID: 4402478
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug.
    Boissier JR; Giudicelli JF; Viars P; Advenier C; Mouille P; Larno S
    Eur J Pharmacol; 1971 Jul; 15(2):151-9. PubMed ID: 4403548
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of the local anaesthetic-, "quinidine-like"- and adrenergic beta-blocking-activities of five beta-receptor antagonists.
    Davis WG
    J Pharm Pharmacol; 1970 Apr; 22(4):284-90. PubMed ID: 4392570
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of propranolol, oxprenolol, and practolol on denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br Heart J; 1971 Jul; 33(4):614-5. PubMed ID: 4397631
    [No Abstract]   [Full Text] [Related]  

  • 37. Properties of 1-isopropylamino-3-(4-indanoxy)-2-propanol (USVC 6524), an adrenergic -receptor blocking agent.
    Marmo E; Saini RK; Caputi AP
    Farmaco Prat; 1972 Dec; 27(12):661-87. PubMed ID: 4405106
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental research on the action of beta-adrenergic receptor blocking agents].
    Valora N; Fidanza A; Floridi S
    Arch Fisiol; 1969 Dec; 67(3):251-72. PubMed ID: 4394262
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of a few -sympatholytics (propranolol, C.39'089-Ba, H56-28 and Ko 592) on serum cholinesterase of rats].
    Marmo E
    Jpn J Pharmacol; 1971 Jun; 21(3):421-3. PubMed ID: 4397670
    [No Abstract]   [Full Text] [Related]  

  • 40. Pressor action of beta blocking agents in rats.
    Regoli D
    Can J Physiol Pharmacol; 1970 Jul; 48(7):481-9. PubMed ID: 5430353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.